Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed/refractory large B-cell lymphoma Research Letter
| Authors: | Falchi, L.; Hutchings, M.; Carlo-Stella, C.; Morschhauser, F.; Dickinson, M.; Cartron, G.; Khan, C.; Tani, M.; Martinez-Lopez, J.; Bartlett, N. L.; Salar, A.; Brody, J. D.; Leppä, S.; Berthier, A.; Kallemeijn, M.; Relf, J.; Tchaleu, F. B.; Lundberg, L.; Bachy, E. |
| Title: | Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed/refractory large B-cell lymphoma |
| Keywords: | adult; cancer chemotherapy; controlled study; aged; major clinical study; overall survival; prednisone; drug efficacy; drug safety; cancer grading; letter; progression free survival; multiple cycle treatment; phase 2 clinical trial; dexamethasone; histology; intensive care unit; prednisolone; paracetamol; multicenter study; methylprednisolone; phase 1 clinical trial; corticosteroid; non-hodgkin lymphoma; artificial ventilation; diphenhydramine; premedication; cytokine release syndrome; overall response rate; diffuse large b cell lymphoma; tocilizumab; very elderly; human; male; female; article; obinutuzumab; positron emission tomography-computed tomography; ecog performance status; glofitamab |
| Journal Title: | Haematologica |
| Volume: | 110 |
| Issue: | 4 |
| ISSN: | 0390-6078 |
| Publisher: | Ferrata Storti Foundation |
| Date Published: | 2025-04-01 |
| Start Page: | 999 |
| End Page: | 1004 |
| Language: | English |
| DOI: | 10.3324/haematol.2024.286257 |
| PUBMED: | 39605203 |
| PROVIDER: | scopus |
| PMCID: | PMC11959244 |
| DOI/URL: | |
| Notes: | Letter -- MSK corresponding author is Lorenzo Falchi -- Source: Scopus |
